HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Tumor Heterogeneity

Tumor Heterogeneity

Tumor heterogeneity, a hallmark of cancer, refers to the presence of diverse cell populations within a tumor. These cells vary in genetic, epigenetic, and phenotypic characteristics, leading to differences in proliferation rates, drug sensitivity, and metastatic potential. Understanding tumor heterogeneity is crucial for developing effective treatment strategies. Techniques like single-cell sequencing and spatial profiling have unveiled the intricate landscape of tumor heterogeneity, revealing subclones and microenvironments that influence disease progression and therapy response. Leveraging this knowledge, researchers aim to personalize cancer treatment by targeting specific tumor cell populations and their associated vulnerabilities. By unraveling the complexity of tumor heterogeneity, scientists strive to improve patient outcomes and pave the way for precision oncology.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp